welbournes

MHRA Class 4 Medicines Defect Notification: Ocumont Eye Ointment 1% w/w Blumont Pharma Limited Drug alert number: EL(26)A/03 Date issued: 27 January 2026 Blumont Pharma Limited is reporting to the MHRA regarding the absence of Braille on the outer carton of one batch of Ocumont Eye Ointment 1% w/w (POM). It was identified that the Braille [...]

The post MHRA Class 4 Medicines Defect Notification: Ocumont Eye Ointment 1% w/w Blumont Pharma Limited appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (23/01/2026) confirmed the following list of price concessions for January 2026: Drug Pack size Price concession Alfuzosin 2.5mg tablets 60 £6.54 Aspirin 75mg gastro-resistant tablets 28 £1.00 Clomipramine 50mg capsules 28 £6.89 Cyclizine 50mg/1ml solution for injection ampoules 5 £3.59 Duloxetine 60mg gastro-resistant capsules 28 [...]

The post January 2026 Price Concessions 2nd Update appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (16/01/2026) confirmed the following initial list of price concessions for January 2026: Drug Pack size Price concession Amoxicillin 250mg/5ml oral suspension 100 £1.44 Aspirin 75mg dispersible tablets 28 £2.19 Aspirin 75mg dispersible tablets 100 £7.82 Betamethasone 500microgram soluble tablets sugar free 100 £47.89 Carbocisteine 375mg [...]

The post January 2026 Price Concessions 1st Update appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Buprenorphine/naloxone (Suboxone®) 2mg/500microgram and 8mg/2mg sublingual tablets. MSN/2026/002 Tier 2 – Medium impact Date of issue: 15 January 2026 Buprenorphine/naloxone (Suboxone®) 2mg/500microgram and 8mg/2mg sublingual tablets were discontinued on 5th January 2026. Various strengths (0.7mg/0.18mg, 1.4mg/0.36mg, 5.7mg/1.4mg, 8.6mg/2.1mg, and 11.4mg/2.9mg) of [...]

The post Medicine Supply Notification: Buprenorphine/naloxone (Suboxone® ) 2mg/500microgram and 8mg/2mg sublingual tablets appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Co-codamol 30mg/500mg tablets. MSN/2026/001 Tier 3 – High impact Date of issue: 12 January 2026 Co-codamol 30mg/500mg tablets will be in limited supply from early February until early June 2026. Paracetamol 500mg tablets remain available and can support a full uplift [...]

The post Medicine Supply Notification: Co-codamol 30mg/500mg tablets appeared first on Community Pharmacy England.